MEL Science raised €5.2M in a Series C round in Jan 2019. The company is based in Sankt-Peterburg, Russia. Investors in the round: TMT Investments. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.